RHONDA BERGERON: Open Payments
NPI 1336250182 · PORT BARRE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 22 payments from 12 companies in 2025. Trend: 2023 $458 · 2024 $811 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Penumbra, Inc. | 1 | $147 |
| Lilly USA, LLC | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Viatris Specialty LLC | 3 | $51 |
| ABBVIE INC. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $24 |
Products named: Indigo System, CAPLYTA, MOUNJARO, YUPELRI, VRAYLAR, Ozempic, Auvelity, Korlym.
Industry payments across LA — which companies pay providers there.
